logo

Akcea Therapeutics Inc. (AKCA)



Trade AKCA now with
  Date
  Headline
11/29/2018 7:09:21 AM Akcea Therapeutics To Present Long-term Analyses Of NEURO-TTR Open-label Extension Study At ASH Annual Meeting
11/12/2018 6:57:41 AM Akcea : Phase 2 Results On AKCEA-APO-LRx Presented In Late-Breaking Clinical Trial Presentation
11/6/2018 7:19:14 AM Ionis Pharma Q3 Net Loss $5 Mln Vs. Net Loss $3 Mln Last Year
11/5/2018 4:12:13 PM Akcea Therapeutics Q3 EPS $0.73 Vs. Loss $0.33 Year Ago
10/10/2018 9:08:09 AM Ionis Announces New Collaboration With Roche To Develop IONIS-FB-LRx For Treatment Of Complement-mediated Diseases
10/8/2018 7:02:56 AM Akcea Therapeutics: Damien McDevitt Replaces Stanley Crooke On Board
9/24/2018 7:04:09 AM Akcea And Ionis Report Positive Data From Phase 2 Study Of AKCEA-APO(a)-LRx
8/7/2018 7:17:40 AM Ionis Q2 Loss Per Share $0.29 Vs Loss $0.02 Last Year
8/2/2018 8:12:24 AM Akcea Therapeutics And PTC Therapeutics Collaborate To Commercialize Two Rare Disease Drugs In Latin America
7/11/2018 7:31:29 AM Akcea And Ionis Announce Approval Of TEGSEDI In The European Union